We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid Solutions for Point-of-Care Diagnostics Provided Worldwide

By LabMedica International staff writers
Posted on 15 Jun 2009
A range of rapid diagnostic tests used for the detection of infectious diseases offers fast and cost-effective clinical solutions for point-of-care diagnostic testing.

The QuickVue range includes qualitative detection of influenza type A and type B antigens, a dipstick immunoassay for acute respiratory syncytial virus (RSV) infections, and a one-step human chorionic gonadotropin (hCG) test, as well as quick and simple tests for Helicobacter pylori, Chlamydia, and Streptococcus group A infections.

BioMerieux (Marcy l'Etoile, France) is now supplying the QuickVue range of rapid diagnostic tests worldwide, as part of a global alliance with Quidel Corp. More...
(San Diego, CA, USA) for the development and distribution of rapid clinical diagnostic solutions. Many new tests are in the development pipeline.

The long-term global alliance between Quidel and bioMérieux was originally formed in 2008. The two companies planned to codevelop new rapid tests using Quidel's rapid test development capability and bioMérieux's expertise in immunochemistry and wide-ranging library of biologics, including antibodies and antigens.

BioMerieux provides diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination. Its products are used for diagnosing infectious diseases, for providing results for cancer screening and monitoring, and cardiovascular emergencies.

Quidel develops rapid diagnostic tests that allow for the movement of patient testing out of the central laboratory setting and into the physician office, urgent care, and other outpatient settings where rapid testing and treatment has an impact on clinical outcomes and provides an economic benefit.

Related Links:

bioMerieux
Quidel



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.